Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Prophylaxis of migraine, vertigo, vestibular, peripheral and cerebrovascular disorders Age: Adult |
Dose: Oral – 5 to 10 mg Frequency: once daily Note: usually given at night to minimize the effects of drowsiness |
|
Indication: Migraine prophylaxis Age: Adult Condition: patients less than 65 years |
Dose: Oral – 10 mg Frequency: once daily Note: given at night; starting dose |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Prophylaxis of migraine; Prophylaxis of vertigo and vestibular disorders; Prophylaxis of peripheral and cerebrovascular disorders Age: Child |
Dose: Oral – 5 mg Frequency: once daily Note: usually given at night to minimize the effects of drowsiness |
|
Indication: Maintenance treatment for Prophylaxis of migraine, vertigo, vestibular, peripheral and cerebrovascular disorders Age: Child |
Dose: Oral – 5 mg Frequency: 5 days of a week Note: 2 successive drug free days. Treatment should be interrupted after 6 months and re-initiated only if the patient relapses. The recommended maximum daily dose is 5 mg daily in children less than 40 kg |
Administration
- Take with or without food
- Take at bedtime
Side Effect
- Drowsiness
- Rarely weight gain
- headache
- depression
- gastric pain
- dry mouth
- insomnia
- extrapyramidal reactions
- galactorrhoea
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Oral contraceptives
|
Galactorrhea reported in few women within first two months of treatment
|
|
Carbamazepine, Phenytoin
|
Increase metabolism of Flunarizine
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
History of Depressive Illness
|
Can worsen depression
|
|
Pre-existing Parkinson's Disease
|
Can worsen symptoms
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.